





| 카탈로그 번호 | HF855026 |
|---|---|
| 설명 |
Dazukibart (HF855026) is a research-grade recombinant antibody targeting IFNB. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| 종 반응성 | Human |
| 응용 분야 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 숙주 종 | Human |
| 클론성 | Monoclonal |
| 이소타입 | IgG1-kappa |
| 발현 시스템 | Mammalian cells |
| 타겟 | IFNB, IFN-beta, Interferon beta, IFNB1, Fibroblast interferon, IFB |
| 내독소 수준 | < 10 EU/mg |
| 순도 | >95% purity as determined by SDS-PAGE. |
| 정제 | Protein A/G purified from cell culture supernatant. |
| 등록번호 | P01574 |
| 형태 | Liquid |
| 저장 완충액 | 0.01M PBS pH 7.4 데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요. |
| 안정성 및 저장 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 대체 이름 | 2639474-65-8 |
| 배경 | Interferon beta (IFNB1/IFN-beta) is a ~22 kDa protein. Type I interferon cytokine that plays a key role in the innate immune response to infection, developing tumors and other inflammatory stimuli. Signals via binding to high-affinity (IFNAR2) and low-affinity (IFNAR1) heterodimeric receptor, activating the canonical Jak-STAT signaling pathway resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the interferon response, such as antiviral proteins, regulators of cell proliferation and differentiation, and immunoregulatory proteins. Signals mostly via binding to a IFNAR1-IFNAR2 heterodimeric receptor, but can also function with IFNAR1 alone and independently of Jak-STAT pathways. Elicits a wide variety of responses, including antiviral and antibacterial activities, and can regulate the development of B-cells, myelopoiesis and lipopolysaccharide (LPS)-inducible production of tumor necrosis factor. Plays a role in neuronal homeostasis by regulating dopamine turnover and protecting dopaminergic neurons: acts by promoting neuronal autophagy and alpha-synuclein clearance, thereby preventing dopaminergic neuron loss. 1. Russell-Harde, D. et al. (1999) Biochemical and biophysical research communications 255, 539-44. PMID: 10049744 2. Piehler, J. et al. (1999) Journal of molecular biology 294, 223-37. PMID: 10556041 3. Derynck, R. et al. (1980) Nature 285, 542-7. PMID: 6157094 4. Shepard, HM. et al. (1981) Nature 294, 563-5. PMID: 6171735 5. Domanski, P. et al. (1995) The Journal of biological chemistry 270, 21606-11. PMID: 7665574 6. Platanias, LC. et al. (1994) The Journal of biological chemistry 269, 17761-4. PMID: 8027027 7. Croze, E. et al. (1996) The Journal of biological chemistry 271, 33165-8. PMID: 8969169 |
| 참고사항 | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control | Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507) |

SDS-PAGE for Research Grade Dazukibart.

Western blot analysis was performed using anti-IFNB1/IFN-beta monoclonal antibody at 1ug/mL on various samples.
Lane 1: recombinant human IFNB1/IFN-beta (Catalog No: HF855012)
Lane 2: negative control

Detects recombinant human IFNB1/IFN-beta (Catalog No: HF855012) in indirect ELISA






+86-027-65523339
중국 우한시 심둔사로 666번지 C동, 우한, 430206

中文
English
한국어
日本語
Español
Français
Русский